AU5684086A - Use of an aqueous chlorite matrix solution for the treatment of tumors - Google Patents

Use of an aqueous chlorite matrix solution for the treatment of tumors

Info

Publication number
AU5684086A
AU5684086A AU56840/86A AU5684086A AU5684086A AU 5684086 A AU5684086 A AU 5684086A AU 56840/86 A AU56840/86 A AU 56840/86A AU 5684086 A AU5684086 A AU 5684086A AU 5684086 A AU5684086 A AU 5684086A
Authority
AU
Australia
Prior art keywords
tumors
treatment
matrix solution
aqueous chlorite
chlorite matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU56840/86A
Other versions
AU595514B2 (en
Inventor
Friedrich W. Dr. Kuhne
Kurt-Wilhelm Prof. Dr. Dr. Stahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxo Chemie AG
Original Assignee
Oxo Chemie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxo Chemie GmbH filed Critical Oxo Chemie GmbH
Publication of AU5684086A publication Critical patent/AU5684086A/en
Application granted granted Critical
Publication of AU595514B2 publication Critical patent/AU595514B2/en
Assigned to OXO CHEMIE AG reassignment OXO CHEMIE AG Alteration of Name(s) in Register under S187 Assignors: OXO CHEMIE GMBH
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The solution of a chemically stabilized chlorite matrix is administered intravenously and/or locally for treating tumours.
AU56840/86A 1985-05-02 1986-04-30 Use of an aqueous chlorite matrix solution for the treatment of tumors Ceased AU595514B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853515748 DE3515748A1 (en) 1985-05-02 1985-05-02 USE OF ISOTON CHLORITE MATRIX SOLUTION IN TUMOR TREATMENT
DE3515748 1985-05-02

Publications (2)

Publication Number Publication Date
AU5684086A true AU5684086A (en) 1986-11-06
AU595514B2 AU595514B2 (en) 1990-04-05

Family

ID=6269617

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56840/86A Ceased AU595514B2 (en) 1985-05-02 1986-04-30 Use of an aqueous chlorite matrix solution for the treatment of tumors

Country Status (6)

Country Link
EP (1) EP0200156B1 (en)
JP (1) JPS6230715A (en)
AT (1) ATE75144T1 (en)
AU (1) AU595514B2 (en)
CA (1) CA1268714A (en)
DE (2) DE3515748A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU595515B2 (en) * 1985-05-02 1990-04-05 Oxo Chemie Ag Aqueous chlorite matrix solution
AU599027B2 (en) * 1985-05-02 1990-07-12 Oxo Chemie Ag Use of an aqueous, stabilised chlorite matrix solution for infectious conditions

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3600931A1 (en) * 1986-01-15 1987-07-16 Oxo Chemie Gmbh Formulation of chlorite matrices in solution
US4851222A (en) * 1988-01-27 1989-07-25 Oxo Chemie Gmbh Method of promoting regeneration of bone marrow
DE4208828A1 (en) * 1992-03-19 1993-09-23 Oxo Chemie Gmbh USE OF A CHEMICALLY STABILIZED CHLORITE MATRIX FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV INFECTIONS
CA2382293A1 (en) * 1999-08-18 2001-02-22 Oxo Chemie Ag Chemically-stabilized chlorite solutions for treating cancer and other diseases
DE10127729C2 (en) * 2001-06-07 2003-05-28 P & W Invest Vermoegensverwalt Stable aqueous chlorine-oxygen solution which is essentially free of chlorite, process for its preparation and its use
EP2428213A1 (en) * 2005-07-21 2012-03-14 Nuvo Research AG Stabilized chlorite solutions in combination with fluoropyrimidines for use in cancer treatment
EP1979269A4 (en) * 2005-12-22 2013-01-02 Taiji Biomedical Inc Chlorite formulations, and methods of preparation and use thereof
EP2517713A3 (en) 2007-06-01 2013-01-30 Nuvo Research AG A method of treating allergic asthma, allergic rhinitis and atopic dermatitis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU68443A1 (en) * 1946-07-09 1977-02-25 Method of treating skin cancers
US4296103A (en) * 1980-08-08 1981-10-20 Felipe Laso Stabilized solution of chlorine oxides
DE3213389A1 (en) * 1982-04-10 1983-10-20 Friedrich-Wilhelm Dr. 7107 Neckarsulm Kühne STABILIZED ACTIVATED OXYGEN AND MEDICINAL PRODUCTS CONTAINING THIS STABILIZED ACTIVATED OXYGEN
EP0136309B1 (en) * 1983-02-25 1987-05-06 BERGER, Peter Method for producing a modified aqueous chlorite solution, solution produced thereby and utilization thereof
DE3515745A1 (en) * 1985-05-02 1986-11-06 Oxo Chemie GmbH, 6900 Heidelberg AQUEOUS CHLORITE MATRIX SOLUTION

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU595515B2 (en) * 1985-05-02 1990-04-05 Oxo Chemie Ag Aqueous chlorite matrix solution
AU599027B2 (en) * 1985-05-02 1990-07-12 Oxo Chemie Ag Use of an aqueous, stabilised chlorite matrix solution for infectious conditions

Also Published As

Publication number Publication date
ATE75144T1 (en) 1992-05-15
EP0200156B1 (en) 1992-04-22
EP0200156A3 (en) 1989-05-10
DE3515748A1 (en) 1986-11-06
EP0200156A2 (en) 1986-11-05
JPH026740B2 (en) 1990-02-13
JPS6230715A (en) 1987-02-09
DE3684953D1 (en) 1992-05-27
AU595514B2 (en) 1990-04-05
CA1268714A (en) 1990-05-08

Similar Documents

Publication Publication Date Title
MY106263A (en) Method for the treatment or prevention of intrinsically aged skin with retinoids
AU6857887A (en) Therapeutic agent
AU3256789A (en) Topical preparation for treating otopathy
AU5684086A (en) Use of an aqueous chlorite matrix solution for the treatment of tumors
AU2883689A (en) The use of moclobemide to treat or prevent cognitive disorders
AU2158688A (en) Use of bezafibrate for treating diabetes
AU6142186A (en) Use of melatonin or related compounds for the treatment of psoriasis
AU569354B2 (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
AU7999687A (en) Active compounds for preventing tumor metastases
ZA857721B (en) Process for treatment of rheumatic diseases
EP0333831A4 (en) Use of metalloporphyrins to reverse the toxic effect of tumor therapy.
EP0285906A3 (en) Active agent for combating tumours
AU7719491A (en) Therapeutic compound
AU612267B2 (en) Medicaments
AU1162788A (en) Oxime-ethers of 2,6-dioxobicyclo-(3.3.0)octanones for treatment of heart and circulation diseases
Richardson Cognitive-behavioral therapy for the treatment of headaches diagnosed as common migraine a minimal-therapist-contact approach versus a clinic-based approach.
AU3430189A (en) Compounds for diagnosis and/or therapy of tumours
GR3006404T3 (en)
UA16000A1 (en) Method for treatment of hypotrophy in piglings
AU7931487A (en) Therapeutic treatment of abnormal cell growth with follicle regulatory protein
IT1245368B (en) Compound with calcium antagonistic activity

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired